Is an atrial defibrillator still an option in treating patients with atrial fibrillation?

Ziad El Khoury, Deepak Bhakta

Research output: Contribution to journalArticle

Abstract

Atrial fibrillation (AF) is a common disorder associated with significant morbidities and presents several challenges for the control of symptoms and prevention of long-Term implications. Atrial defibrillators (ADs), used for rhythm control in patients with symptoms refractory to medical therapy, can detect recurrences of the arrhythmia, allow prompt patient-directed treatment, and have the potential to reduce hospitalizations and improve quality of life. The efficacy of this form of therapy is highest in patients with paroxysmal AF, and with the use of a coronary sinus shocking lead. While R-wave synchronized shocks are a prerequisite for a safe use, the procedure is well tolerated and usually not associated with long-Term psychological side effects. Limitations of ADs include acute and chronic complications related to cardiac rhythm device implantation, the requirement in some cases for more than one shock to terminate AF, the discomfort from shocks, as well as the need for sedation to alleviate pain from the shocks. With the ever-expanding role of catheter-based therapies for AF, it seems that the role of ADs in this regard is rather limited.

Original languageEnglish
Pages (from-to)124-130
Number of pages7
JournalJournal of Atrial Fibrillation
Volume5
Issue number5
StatePublished - Feb 2013

Fingerprint

Defibrillators
Atrial Fibrillation
Shock
Coronary Sinus
Therapeutics
Cardiac Arrhythmias
Hospitalization
Catheters
Quality of Life
Psychology
Morbidity
Recurrence
Pain
Equipment and Supplies

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Is an atrial defibrillator still an option in treating patients with atrial fibrillation? / El Khoury, Ziad; Bhakta, Deepak.

In: Journal of Atrial Fibrillation, Vol. 5, No. 5, 02.2013, p. 124-130.

Research output: Contribution to journalArticle

@article{468d5764ffb5452f86e3d1b9e131fa25,
title = "Is an atrial defibrillator still an option in treating patients with atrial fibrillation?",
abstract = "Atrial fibrillation (AF) is a common disorder associated with significant morbidities and presents several challenges for the control of symptoms and prevention of long-Term implications. Atrial defibrillators (ADs), used for rhythm control in patients with symptoms refractory to medical therapy, can detect recurrences of the arrhythmia, allow prompt patient-directed treatment, and have the potential to reduce hospitalizations and improve quality of life. The efficacy of this form of therapy is highest in patients with paroxysmal AF, and with the use of a coronary sinus shocking lead. While R-wave synchronized shocks are a prerequisite for a safe use, the procedure is well tolerated and usually not associated with long-Term psychological side effects. Limitations of ADs include acute and chronic complications related to cardiac rhythm device implantation, the requirement in some cases for more than one shock to terminate AF, the discomfort from shocks, as well as the need for sedation to alleviate pain from the shocks. With the ever-expanding role of catheter-based therapies for AF, it seems that the role of ADs in this regard is rather limited.",
author = "{El Khoury}, Ziad and Deepak Bhakta",
year = "2013",
month = "2",
language = "English",
volume = "5",
pages = "124--130",
journal = "Journal of Atrial Fibrillation",
issn = "1941-6911",
publisher = "Cardiofront, Inc.",
number = "5",

}

TY - JOUR

T1 - Is an atrial defibrillator still an option in treating patients with atrial fibrillation?

AU - El Khoury, Ziad

AU - Bhakta, Deepak

PY - 2013/2

Y1 - 2013/2

N2 - Atrial fibrillation (AF) is a common disorder associated with significant morbidities and presents several challenges for the control of symptoms and prevention of long-Term implications. Atrial defibrillators (ADs), used for rhythm control in patients with symptoms refractory to medical therapy, can detect recurrences of the arrhythmia, allow prompt patient-directed treatment, and have the potential to reduce hospitalizations and improve quality of life. The efficacy of this form of therapy is highest in patients with paroxysmal AF, and with the use of a coronary sinus shocking lead. While R-wave synchronized shocks are a prerequisite for a safe use, the procedure is well tolerated and usually not associated with long-Term psychological side effects. Limitations of ADs include acute and chronic complications related to cardiac rhythm device implantation, the requirement in some cases for more than one shock to terminate AF, the discomfort from shocks, as well as the need for sedation to alleviate pain from the shocks. With the ever-expanding role of catheter-based therapies for AF, it seems that the role of ADs in this regard is rather limited.

AB - Atrial fibrillation (AF) is a common disorder associated with significant morbidities and presents several challenges for the control of symptoms and prevention of long-Term implications. Atrial defibrillators (ADs), used for rhythm control in patients with symptoms refractory to medical therapy, can detect recurrences of the arrhythmia, allow prompt patient-directed treatment, and have the potential to reduce hospitalizations and improve quality of life. The efficacy of this form of therapy is highest in patients with paroxysmal AF, and with the use of a coronary sinus shocking lead. While R-wave synchronized shocks are a prerequisite for a safe use, the procedure is well tolerated and usually not associated with long-Term psychological side effects. Limitations of ADs include acute and chronic complications related to cardiac rhythm device implantation, the requirement in some cases for more than one shock to terminate AF, the discomfort from shocks, as well as the need for sedation to alleviate pain from the shocks. With the ever-expanding role of catheter-based therapies for AF, it seems that the role of ADs in this regard is rather limited.

UR - http://www.scopus.com/inward/record.url?scp=84875497266&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84875497266&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:84875497266

VL - 5

SP - 124

EP - 130

JO - Journal of Atrial Fibrillation

JF - Journal of Atrial Fibrillation

SN - 1941-6911

IS - 5

ER -